The effect of caper oxymel on loosing weight, decressing blood suger and blood fat and lowering blood pressure in diabetic patients
- Conditions
- Diabete.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT2016100630175N1
- Lead Sponsor
- Research and Technology Vice-Chancellory of Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 42
Diabetic patients (type 2) whose disease has not been controlled inspit of taking complete oral medication based on ADA and they do not accept to take insulin? Ages between 30-65 years old? Definitive diagnosis of metabolic syndrom based on NECP:ATPIII diagnostic criteria
exclusion criteria:
Dissatisfaction with continuing participation? Necessity of any new therapeutic intervension during the study based on endocrinologist? Breast feeding and lactation? Complications such as increasing blood presure, chest pain, fatigue during treatment? Renal problem with increasing creatinine and decreasing GFR less than 60? Any systematic disease which influence on trend of disease such as cardiac diseases, liver problems and malignancies?Acute or sever complications of diabete such as DKA, hyperosmolar coma and sever hypoglycemia in recent 3 months? The critical illness which leads to hospitalisation in recent 3 months? Taking hyperglycemic agent such as immunosupressive and antileptic
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Waist circumference. Timepoint: Before in intervention, one month, two month and after intervention. Method of measurement: Using a tape in order to measure in cm.;Fasting blood suger. Timepoint: Before in intervention, one month, two month and after intervention. Method of measurement: Measuring by blood tests in mg/dl.;Lipid profil. Timepoint: Before and after intervention. Method of measurement: Measuring by blood tests in mg/dl.;HbA1c. Timepoint: Before and after intervention. Method of measurement: Measuring by blood tests in %.;Blood pressure. Timepoint: Before in intervention, one month, two month and after intervention. Method of measurement: Measuring by sphygmomanometer in mm/hg.;Microalbuminuria. Timepoint: Before and after intervention. Method of measurement: Measuring by urine tests in mg/l.;CRP. Timepoint: Before and after intervention. Method of measurement: Measuring by blood tests in mg/l.
- Secondary Outcome Measures
Name Time Method SGOT. Timepoint: Before in intervention, one month, two month and after intervention. Method of measurement: Measuring by blood tests in IU/L.;SGPT. Timepoint: Before in intervention, one month, two month and after intervention. Method of measurement: Measuring by blood tests in IU/L.;ALP. Timepoint: Before in intervention, one month, two month and after intervention. Method of measurement: Measuring by blood tests in IU/L.;Creatinie. Timepoint: Before in intervention, one month, two month and after intervention. Method of measurement: Measuring by blood tests in mg/dl.